Lactate Therapy After Traumatic Brain Injury (LS_TCC)
Neuroprotective Role of Lactate Therapy in Humans With Traumatic Brain Injury
Sponsor: Centre Hospitalier Universitaire Vaudois
A NA clinical study on Subarachnoid Hemorrhage and Traumatic Brain Injury, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire Vaudois and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2021 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status NA
-
Apr 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Apr 2020 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — May 2018 [monthly]
Recruiting PHASE2
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire Vaudois
- European Society of Intensive Care Medicine
- Swiss National Science Foundation
For direct contact, visit the study record on ClinicalTrials.gov .